By Matt Grossman
Synlogic Inc. and Roche Holding AG will collaborate on research into a treatment for inflammatory bowel disease, Synlogic said Thursday.
Following the research period established by the agreement, Roche will have an exclusive option for a licensing and collaboration agreement for further development and commercialization, according to Synlogic, a Cambridge, Mass. based pharmaceutical company.
Write to Matt Grossman at email@example.com
(END) Dow Jones Newswires